Skip to main content
SpringerLink
Log in

Pulmonale Erkrankungen

  • Chapter
Neugeborenen-intensivmedizin

  • 1451 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ainsworth SB, Beresford MW, Milligan DW, Shaw NJ, Matthews JN, Fenton AC, Ward Platt MP (2000) Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks’ gestation: a randomised trial. Lancet. 355:1387–1392

    Article  PubMed  CAS  Google Scholar 

  2. Arias Camison JM, Lau J, Cole CH, Frantz ID 3rd (1999) Meta analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 28:167–174

    Article  PubMed  CAS  Google Scholar 

  3. Askie LM, Henderson-Smart DJ, Irwig L et al. (2003) Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349: 959–967

    Article  PubMed  CAS  Google Scholar 

  4. Bancalari E, Claure N, Gonzales A (2005) Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 88:192–201

    Article  PubMed  Google Scholar 

  5. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA (1999) Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181:709–717

    Article  PubMed  CAS  Google Scholar 

  6. Barrington KJ, Finer NN (2006) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev CD000509

    Google Scholar 

  7. Baud O, Foix L’Helias L, Kaminski M et al. (1999) Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 341:1190–1196

    Article  PubMed  CAS  Google Scholar 

  8. Baud O, Laudenbach V, Evrard P, Gressens P (2001) Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: Role of preservatives. Pediatr Res 50: 706–711

    PubMed  CAS  Google Scholar 

  9. Bell EF, Acarregui MJ (2001) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000503

    Google Scholar 

  10. Bent RC, Wiswell TE, Chang A (1992) Removing meconium from infant tracheae. What works best? Am J Dis Child 146:1085–1089

    PubMed  CAS  Google Scholar 

  11. Bevilacqua G, Parmigiani S, Robertson B (1996) Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial. J Perinat Med 24:1–12

    Google Scholar 

  12. Bibi H, Seifert B, Oulette M, Belik J (1992) Intratracheal N-acetylcysteine use in infants with chronic lung disease. Acta Paediatr Scand 81:335–339

    CAS  Google Scholar 

  13. Bloom BT, Kattwinkel J, Hall RT et al. (1997) Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 100:31–38

    Article  PubMed  CAS  Google Scholar 

  14. Brion LP, Primhak RA (2000) Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev CD001453

    Google Scholar 

  15. Brion LP, Primhak RA, Yong W (2001) Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev CD001694

    Google Scholar 

  16. Brion LP, Soll RF (2001) Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev CD001454

    Google Scholar 

  17. Brion LP, Primhak RA, Ambrosio Perez I (2002) Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev CD001817

    Google Scholar 

  18. Carlo WA, Stark AR, Wright LL et al. (2002) Minimal ventilation to prevent bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 141: 370–374

    Article  PubMed  Google Scholar 

  19. Chan V, Greenough A, Gamsu HR (1992) Neonatal complications of extreme prematurity in mechanically ventilated infants. Eur J Pediatr 151:693–696

    Article  PubMed  CAS  Google Scholar 

  20. Charafeddine L, D’Angio CT, Phelps DL (1999) Atypical chronic lung disease patterns in neonates. Pediatrics 103:759–765

    Article  PubMed  CAS  Google Scholar 

  21. Christensen RD, Hunter DD, Goodell H, Rothstein G (1992) Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. J Pediatr 120:593–598

    Article  PubMed  CAS  Google Scholar 

  22. Cole CH, Colton T, Shah BL, Abbasi S, MacKinnon BL, Demissie S, Frantz ID 3rd (2000) Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia N Engl J Med 340:1005–1010

    Article  Google Scholar 

  23. Collaborative Dexamethasone Trial Group (1991) Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 88: 421–427

    Google Scholar 

  24. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N et al. (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible my mineralocorticoid receptor activation. Molecular Psychiatry 10: 790–798

    Article  PubMed  CAS  Google Scholar 

  25. Crowley, P (2000) Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev CD000065

    Google Scholar 

  26. Darlow BA, Graham PJ (2002) Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev CD000501

    Google Scholar 

  27. Day RW, Lynch JM, White KS, Ward RM (1996) Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 98:698–705

    PubMed  CAS  Google Scholar 

  28. Doyle LW, Davis PG, Morley CJ, McPhee A et al. (2006) Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 117: 75–83

    Article  PubMed  Google Scholar 

  29. Durand M, Sardesai S, McEvoy C (1995) Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics 95: 584–590

    PubMed  CAS  Google Scholar 

  30. Eronen M, Pohjavuori M, Andersson S, Pesonen E, Raivio KO (1997) Prostacyclin treatment for persistent pulmonary hypertension of the newborn. Pediatr Cardiol 18:3–7

    Article  PubMed  CAS  Google Scholar 

  31. Fanaroff AA, Hack M (1999) Periventricular leukomalacia prospects for prevention. N Engl J Med 14 341:1229–1231

    Article  PubMed  CAS  Google Scholar 

  32. Flenady VJ, Gray PH (2000) Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. Cochrane Database Syst Rev CD000283

    Google Scholar 

  33. Fowlie PW, Davis PG (2003) Prophylactic indomethacin for preterm infants: A systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 88: F464–F466

    Article  PubMed  CAS  Google Scholar 

  34. Gonzales A, Sosenko IRS, Chandar J et al. (1996) Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 128: 470–478

    Article  Google Scholar 

  35. Grohmann K, Varon R, Stolz P et al. (2003) Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) Ann Neurol 54: 719–724

    Article  PubMed  CAS  Google Scholar 

  36. Halliday HL (1996) Natural vs. synthetic surfactants in neonatal respiratory distress syndrome. Drugs 51:226–237

    PubMed  CAS  Google Scholar 

  37. Halliday HL (2000) Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. Cochrane Database Syst Rev CD000500

    Google Scholar 

  38. Halliday HL, Ehrenkranz RA, Doyle LW (2003) Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001144

    Google Scholar 

  39. Halliday HL, Ehrenkranz RA (2000) Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001145

    Google Scholar 

  40. Halliday HL, Ehrenkranz RA, Doyle LW (2003) Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001146

    Google Scholar 

  41. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC (1993) Multicentre randomised trial comparing high and low dose surfactant regimes for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 69:276–280

    PubMed  CAS  Google Scholar 

  42. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M (1992) Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 326:1233–1239

    Article  PubMed  CAS  Google Scholar 

  43. Harding JE, Miles FK, Becroft DM, Allen BC, Knight DB (1998) Chest physiotherapy may be associated with brain damage in extremely premature infants. J Pediatr 132:440–444

    Article  PubMed  CAS  Google Scholar 

  44. Hellström-Westas L, Bell AH, Skov L, Greisen G, Svenningsen NW (1992) Cerebro-electrical depression following surfactant treatment in preterm neonates. Pediatrics 89:643–647

    PubMed  Google Scholar 

  45. Hill A, Perlman JM, Volpe JJ (1982) Relationship of pneumothorax to occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics 69:144–149

    PubMed  CAS  Google Scholar 

  46. Hjalmarson O (1981) Epidemiology and classification of acute neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 70: 773–783

    PubMed  CAS  Google Scholar 

  47. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD (1997) Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 25:352–359

    Article  PubMed  CAS  Google Scholar 

  48. Howlett A, Ohlsson A (2003) Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev CD000366

    Google Scholar 

  49. Izraeli S, Samra Z, Sirota L, Merlob P, Davidson (1991) Genital mycoplasmas in preterm infants: prevalence and clinical significance. Eur J Pediatr 150:804–807

    Article  PubMed  CAS  Google Scholar 

  50. Jobe AH (2000) Which surfactant for treatment of respiratory-distress syndrome. Lancet 355:1380–1381

    Article  PubMed  CAS  Google Scholar 

  51. Jobe AH (1999) The new BPD: an arrest of lung development. Pediatr Res 46:641–643

    PubMed  CAS  Google Scholar 

  52. Jobe AH, Bancalari E (2001) Bronchopulmonary Dyplasia. Am J Respir Crit Care Med 163: 1723–1729

    PubMed  CAS  Google Scholar 

  53. Kattner E, Metze B, Waiß E, Obladen M (1992) Accelerated lung maturation following maternal steroid treatment in infants born before 30 weeks gestation. J Perinat Med 20:449–457

    Article  PubMed  CAS  Google Scholar 

  54. Kinsella JP, Truog WE, Walsh WF et al. (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131:55–62

    Article  PubMed  CAS  Google Scholar 

  55. Kukkonen AK, Virtanen M, Järvenpää AL, Pokela ML, Ikonen S, Fellmann V (2000) Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Padiatr 89:556–561

    Article  CAS  Google Scholar 

  56. Lam BC, Yeung CY (1999) Surfactant lavage for meconium aspiration syndrome: A pilot study. Pediatrics 103: 1014–1018

    Article  PubMed  CAS  Google Scholar 

  57. Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M et al. (2005) Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 116: 1–7

    Article  PubMed  Google Scholar 

  58. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL (2003) Erythromycin for the prevention of chronic lung disease in inubated preterm infants a risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev CD003744

    Google Scholar 

  59. Milner AD (1994) Nitric oxide. Eur J Pediatr 153:7–11

    Article  Google Scholar 

  60. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, Jolesz FA, Volpe JJ (2001) Impaired cerebral cortical grey matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 107: 217–221

    Article  PubMed  CAS  Google Scholar 

  61. Ng PC, Brownlee KG, Dear PRF (1991) Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child 66:1164–1166

    Article  PubMed  CAS  Google Scholar 

  62. Ng GY, Ohlsson A (2001) Cromolyn sodium for the prevention of chronic lung disease in preterm infants. Cochrane Database Syst Rev CD003059

    Google Scholar 

  63. Ng GYT, Silva O da, Ohlsson A (2001) Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev CD03214

    Google Scholar 

  64. Northway WH, Moss RB, Carlisle et al. (1990) Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 323:1793–1799

    Article  PubMed  Google Scholar 

  65. Ollikainen J, Hiekkaniemi H, Korppi M, Sarkkinen H, Heinonen K (1993) Ureaplasma urealyticum infection associated with acute respiratory insufficiency and death in premature infants. J Pediatr 122:756–760

    PubMed  CAS  Google Scholar 

  66. O’Neil EA, Chwals WJ, O’Shea MD, Turner CS (1991) Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complication. Arch Dis Child 67:10–11

    Google Scholar 

  67. Papile LA, Tyson JE, Stoll BJ et al. (1998) Multicenter trial of two dexamethasone regimens in ventilator dependent premature infants. N Engl J Med 338:1112–1118

    Article  PubMed  CAS  Google Scholar 

  68. Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM (1998) Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1 beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 17:321–328

    Article  PubMed  CAS  Google Scholar 

  69. Pearson E, Bose C, Snidow T, Ransom L, Young T, Bose G, Stiles A (1992) Trial of vitamin A supplementation in very low birthweight infants at risk for bronchopulmonary dysplasia. J Pediatr 121:420–427

    Article  PubMed  CAS  Google Scholar 

  70. Poets CF, Sens B (1996) Changes in intubation rates and outcome of very low birth weight infants: A population based study. Pediatrics 98: 24–27

    PubMed  CAS  Google Scholar 

  71. Roberts JD Jr, Fineman JR, Morin FC 3rd et al. (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336:605–10

    Article  PubMed  CAS  Google Scholar 

  72. Rojas MA, Gonzales A, Bancalari E, Claure N et al. (1995) Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126: 605–610

    Article  PubMed  CAS  Google Scholar 

  73. Schelonka RL, Katz B, Waites KB, Benjamin DK Jr (2005) Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 24:1033–1039

    Article  PubMed  Google Scholar 

  74. Shah V, Ohlsson A, Halliday HL, Dunn MS (2000) Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev CD001969

    Google Scholar 

  75. Shah P, Ohlsson A (2001) Alpha-1 proteinase inhibitor (α1PI) for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev CD002775

    Google Scholar 

  76. Shah SS, Ohlsson A, Halliday H, Shah VS (2003) Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev CD002057

    Google Scholar 

  77. Shenai JP (1999) Vitamin A supplementation in very low birth weight neonates: rationale and evidence. Pediatrics 104:1369–1374

    Article  PubMed  CAS  Google Scholar 

  78. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM (1988) Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 82:527–532

    PubMed  CAS  Google Scholar 

  79. Shinwell ES, Karplus M, Reich D, Weintraub Z et al. (2000) Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 83: F177–181

    Article  PubMed  CAS  Google Scholar 

  80. Sinkin RA, Cox C, Phelps DL (1990) Predicting risk for bronchopulmonary dysplasia: Selection criteria for clinical trials. Pediatrics 86:728–736

    PubMed  CAS  Google Scholar 

  81. Soll RF (2000) Multiple vs. single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD000141

    Google Scholar 

  82. Soll RF, Blanco F (2001) Natural surfactant extract vs. synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD000144

    Google Scholar 

  83. Soll RF, Morley CJ (2000) Prophylactic vs. selective use of surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000510

    Google Scholar 

  84. Soll RF (2000) Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000511

    Google Scholar 

  85. Soll RF, Dargaville P (2000) Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev CD002054

    Google Scholar 

  86. Speer CP, Robertson B, Curstedt T et al. (1992) Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: Single vs. multiple doses of Curosurf. Pediatrics 89:13–20

    PubMed  CAS  Google Scholar 

  87. Speer CH, Robertson B, Halliday HL (2000) Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Paediatr 89:510–512

    Article  PubMed  CAS  Google Scholar 

  88. Stevens TP, Blennow M, Soll RF (2004) Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants wih or at risk for respiratory distress syndrome. Cochrane Database Syst Rev CD003063

    Google Scholar 

  89. Suresh GK, Davis JM, Soll RF (2001) Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev CD001968

    Google Scholar 

  90. The STOP-ROP Multicenter study group (2000) Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity, a randomized, controlled trial. I: Primary outcomes. Pediatrics 105: 295–310

    Article  Google Scholar 

  91. Tyson JE, Wright LL, Oh W et al. (1999) Vitamin A supplementation for extremelylow-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 340:1962–1968

    Article  PubMed  CAS  Google Scholar 

  92. Van Marter L, Pagano M, Allred EN, Leviton A, Kuban KCK (1992) Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 120:938–946

    Article  PubMed  Google Scholar 

  93. Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA et al. (2005) Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353: 13–22

    Article  PubMed  Google Scholar 

  94. Waites KB, Crouse DT, Cassell GH (1992) Antibiotic susceptibilities and therapeutic options for ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J 11:23–29

    Article  PubMed  CAS  Google Scholar 

  95. Watts JL, Milner R, Zipurski A et al. (1991) Failure of supplementation with Vitamin E to prevent bronchopulmonary dysplasia in infants >1500 g birth weight. Eur Respir J 4:188–190

    PubMed  CAS  Google Scholar 

  96. Werner JC, Sicard RE, Hansen TWR, Solomon E, Cowett RM, Oh W (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary disease. J Pediatr 120:286–291

    Article  PubMed  CAS  Google Scholar 

  97. Wiswell TE, Tuggle JM, Turner BS (1990) Meconium aspiration syndrome: Have we made a difference? Pediatrics 85:715–721

    PubMed  CAS  Google Scholar 

  98. Wood B, Dubik M (1995) A new device for pleural drainage in newborn infants. Pediatrics 96:955–956

    PubMed  CAS  Google Scholar 

  99. Woodgate PG, Davies MW (2001) Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated infants. Cochrane Database Syst Rev CD002061

    Google Scholar 

  100. Yeh TF, Lin YJ, Huang CC et al. (1998) Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101:E7

    Article  PubMed  CAS  Google Scholar 

  101. Yeh TF, Lin YJ, Lin HC, Huang CC et al. (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350:13–7

    Article  Google Scholar 

  102. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI (1997) Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177:825–830

    Article  PubMed  CAS  Google Scholar 

  103. Yost CC, Soll RF (1999) Early vs. delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD001456

    Google Scholar 

  104. Yüksel B, Greenough A, Karani J (1993) Prediction of chronic lung disease from the chest radiograph appearance at seven days of age. Acta Paediatr 82:944–947

    PubMed  Google Scholar 

  105. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B et al. (1999) Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics 103: E24

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Obladen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charité Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin

    Michael Obladen (Direktor der Klinik für Neonatologie) (Direktor der Klinik für Neonatologie)

  2. Universitätsklinikum Gießen/Marburg GmbH, Standort Marburg, Baldinger Straße, 35043, Marburg

    Rolf F. Maier (Direktor des Zentrums für Kinder- und Jugendmedizin) (Direktor des Zentrums für Kinder- und Jugendmedizin)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Obladen, M. (2006). Pulmonale Erkrankungen. In: Obladen, M., Maier, R.F. (eds) Neugeborenen-intensivmedizin. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33738-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33738-6_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33737-9

  • Online ISBN: 978-3-540-33738-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation